Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Lam Research
LRCX
|
$2.04B |
| 2 |
Arista Networks
ANET
|
$2.02B |
| 3 |
Apple
AAPL
|
$1.58B |
| 4 |
Microsoft
MSFT
|
$1.31B |
| 5 |
NVIDIA
NVDA
|
$1.27B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$394M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$354M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$257M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
$126M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$116M |
Sector Composition
| 1 | Technology | 31.84% |
| 2 | Financials | 13.52% |
| 3 | Consumer Discretionary | 11.33% |
| 4 | Healthcare | 10.12% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4376
Hitek Global
HKIT
$43.4M
| $21.7K | ﹤0.01% | 15,178 | – | – |
|
4377
DigiAsia
FAAS
$15M
| $21.7K | ﹤0.01% | 28,884 +14,356 | +99% | +$10.8K |
|
|
HEPA
4378
DELISTED
Hepion Pharmaceuticals
HEPA
| $21.2K | ﹤0.01% | 45,186 -1,840 | -4% | -$865 |
|
4379
Biofrontera
BFRI
$9.45M
| $21K | ﹤0.01% | 19,304 +2,202 | +13% | +$2.4K |
|
|
WINT
4380
DELISTED
Windtree Therapeutics
WINT
| $20.7K | ﹤0.01% | +59,167 | New | +$20.7K |
|
4381
Boxlight
BOXL
$4.76M
| $20.6K | ﹤0.01% | 53,829 -5,441 | -9% | -$2.08K |
|
|
AHG
4382
Akso Health Group
AHG
$939M
| $20.4K | ﹤0.01% | 14,973 | – | – |
|
|
ADAG
4383
Adagene
ADAG
$100M
| $20.1K | ﹤0.01% | 10,309 | – | – |
|
4384
NovaBay Pharmaceuticals
NBY
$10.4M
| $19.9K | ﹤0.01% | 33,030 +6,693 | +25% | +$4.02K |
|
4385
AquaBounty Technologies
AQB
$4.58M
| $19.8K | ﹤0.01% | 31,633 -1,878 | -6% | -$1.18K |
|
4386
Processa Pharmaceuticals
PCSA
$9.52M
| $19.6K | ﹤0.01% | 21,982 +2,289 | +12% | +$2.04K |
|
|
YI
4387
111 Inc
YI
$55.7M
| $19.5K | ﹤0.01% | 31,351 -1,749 | -5% | -$1.09K |
|
|
CLLS
4388
Cellectis
CLLS
$258M
| $19.4K | ﹤0.01% | 10,776 | – | – |
|
|
BKYI
4389
BIO-key International
BKYI
$5.15M
| $19.1K | ﹤0.01% | +11,195 | New | +$19.1K |
|
|
TNFA
4390
TNF Pharmaceuticals, Inc. Common Stock
TNFA
$685K
| $19.1K | ﹤0.01% | 16,571 +602 | +4% | +$692 |
|
4391
NeuroSense Therapeutics
NRSN
$26.5M
| $19K | ﹤0.01% | 15,870 +3,907 | +33% | +$4.69K |
|
|
IMAB
4392
I-MAB
IMAB
$340M
| $18.7K | ﹤0.01% | 22,037 | – | – |
|
4393
Scienjoy Holding
SJ
$27M
| $18.4K | ﹤0.01% | 17,909 | – | – |
|
4394
Artelo Biosciences
ARTL
$12.2M
| $18.4K | ﹤0.01% | 17,350 | – | – |
|
4395
Trio Petroleum
TPET
$9.24M
| $18.2K | ﹤0.01% | 15,021 -252,393 | -94% | -$305K |
|
4396
Beneficient
BENF
$3.51M
| $18.1K | ﹤0.01% | 24,365 +6,815 | +39% | +$5.07K |
|
4397
Kaival Brands Innovations Group
KAVL
$11.5M
| $17.8K | ﹤0.01% | 19,470 +6,089 | +46% | +$5.56K |
|
|
BACK
4398
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $17.3K | ﹤0.01% | 13,587 +1,945 | +17% | +$2.47K |
|
|
TRON
4399
Tron Inc. Common Stock
TRON
$144M
| $16.9K | ﹤0.01% | 26,801 +2,560 | +11% | +$1.61K |
|
|
MMV
4400
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
| $16.7K | ﹤0.01% | +16,568 | New | +$16.7K |
|